🟢ا $BCRX
🔸ا BioCryst Pharma

🔸ا (Q1)ا 2024
خسارة/سهم⬅️0.17$ (متوقع 0.21$)
المبيعـات⬅️92.761 (متوقع 85.605 مليون$)

$BCRX #Biocryst
They have how many outstanding options granted? Its all over the place and they claim only 10m are with execs which would imply each 'normal' employee has about (50M-10m)/500= 80,000 options. Something is not right here.
They want 7M more on the proxy.

BioCryst Pharmaceuticals, Inc. $BCRX
Q1 2024
EARNINGS CALL SUMMARY

BioCryst reports Orladeyo net revenue of $88.9 million in Q1. biomediahub.com/biocryst-repor…

📈 Earnings Reports 📊
$AVTA Avantax, Inc. #AVTA
$SAVA Cassava Sciences, Inc. #SAVA
$MUC BlackRock MuniHoldings California Quality Fund, Inc. #MUC
$PCT PureCycle Technologies, Inc. #PCT
$BCRX BioCryst Pharmaceuticals, Inc. #BCRX

#Trading #Stocks #Market #Investing

📈 Earnings Reports 📊
$AVTA Avantax, Inc. #AVTA
$SAVA Cassava Sciences, Inc. #SAVA
$MUC BlackRock MuniHoldings California Quality Fund, Inc. #M UC
$PCT PureCycle Technologies, Inc. #PCT
$BCRX BioCryst Pharmaceuticals, Inc. #BCRX

#Trading #Stocks #M …

$BCRX
BioCryst presents new real-world evidence indicating substantial reductions in healthcare resource utilization among patients with Hereditary Angioedema after starting Orladeyo (berotralstat).

$BCRX BioCryst shows ORLADEYO® (berotralstat) reduces healthcare resource use for HAE patients.

More Info: pryzm.ozmosi.com/product/16939 $XBI $IBB $XPH $PPH

🔎 Trending Stocks : $BCRX BioCryst Pharmaceuticals Inc #TrendingStocks May 06, 2024 01:00:26 pm dlvr.it/T6VtWg

We heard tons of “wow”s & “cool”s today while the next gen checked out our #biocrust specimens under microscopes & learned bout their importance Las Vegas Science & Technology Festival. Raul Roman Michael Mba kusibu Benjy Luis & A. Alarcon did an amazing job engaging 100s of kiddos #soilcyanobacteria #drylands

🔎 Trending Stocks : $BCRX BioCryst Pharmaceuticals Inc #TrendingStocks May 06, 2024 11:42:16 am dlvr.it/T6VT92

BioCryst to Present at Upcoming Investor Conferences $BCRX healthstockshub.com/news/nasdaq/bc…

BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update $BCRX healthstockshub.com/news/nasdaq/bc…

BioCryst is clearly on a roll, turning heads with their performance and laying down some serious future sales goals. With numbers like these and a confident outlook, make sure to subscribe to the trialtrends.io newsletter to not miss any further updates

$BCRX BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
stocktitan.net/news/BCRX/bio-…

BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update - Yahoo Finance dlvr.it/T6V108

$BCRX
- BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update globenewswire.com/news-release/2…

BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update $BCRX, #BioCrystPharma crweworld.com/article/news-p…